Home Newsfeeds JP Morgan Downgrades Lennar to Neutral, Lowers Price Target to $80

JP Morgan Downgrades Lennar to Neutral, Lowers Price Target to $80

JP Morgan analyst Michael Rehaut downgrades Lennar (NYSE:LEN) from Overweight to Neutral and lowers the price target from $83 to $80.

byBenzinga Newsdesk

July 12, 2022

1 minute read

JP Morgan analyst Michael Rehaut downgrades Lennar (NYSE:LEN) from Overweight to Neutral and lowers the price target from $83 to $80.

Goldman Sachs Maintains Buy on Lululemon Athletica, Raises Price Target to $431 – Removed From Conviction Buy List

By Benzinga Newsdesk

December 9, 1:27 PM

Goldman Sachs analyst Brooke Roach maintains Lululemon Athletica (NASDAQ:LULU) with a Buy and raises the price target from $383 to $431, removed from Conviction Buy List.

LULU

Morgan Stanley Maintains Overweight on IDEX, Raises Price Target to $235

By Benzinga Newsdesk

October 27, 7:58 AM

Morgan Stanley analyst Connor Lynagh maintains IDEX (NYSE:IEX) with a Overweight and raises the price target from $225 to $235.

IEX

MindMed Provides Overview Of Clinical Progress And Corporate Updates At Investor Day

By Happy Mohamed

June 20, 8:37 AM

Mind Medicine (MindMed) Inc (NASDAQ:MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health

MNMD

Good Vs. Evil And Apple: Why Only Heroes Get To Use iPhones?

By Ananya Gairola

August 18, 5:25 AM

Apple's strategic product placement in TV shows and movies often associates iPhones with protagonists, reinforcing a positive brand image and hinting at character alignments in some storylines.

AAPL

JP Morgan Downgrades Lennar to Neutral, Lowers Price Target to $80

Related Posts

Goldman Sachs Maintains Buy on Lululemon Athletica, Raises Price Target to $431 – Removed From Conviction Buy List

Morgan Stanley Maintains Overweight on IDEX, Raises Price Target to $235

MindMed Provides Overview Of Clinical Progress And Corporate Updates At Investor Day

Good Vs. Evil And Apple: Why Only Heroes Get To Use iPhones?